A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Seminars in dialysis
While body-mass index (BMI) is used to diagnose obesity in the general population, its application in the end-stage renal disease (ESRD) population is fraught with difficulty. A major limitation is its inability to distinguish muscle mass from fat mass, thereby leading to misclassification of individuals with poor muscle mass but excess adipose tissue as non-obese (i.e. BMI <30 kg/m 2 ). As muscle wasting is common among ESRD patients, this is an important problem. A substantial proportion ofdoi:10.1111/sdi.12516 pmid:27144783 pmcid:PMC5014614 fatcat:lo3kv2mwdzbfxa44imroeyr77y